| MR编号 | NL/H/6089/001 |
|---|
| 药品名称 | Efluelda |
|---|
| 活性成分 | - influenza virus A/California/7/2009(H1N1) pdm09-like virus 60.0 µg
- influenza virus A/Victoria/361/2011(H3N2)-like virus 60.0 µg
- influenza virus antigen B/Brisbane/60/2008 60.0 µg
|
|---|
| 剂型 | Suspension for injection in pre-filled syringe |
|---|
| 上市许可持有人 | Sanofi Winthrop Industrie
Sanofi Winthrop Industrie
Bp 35
94250 Gentilly
France |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) Efluelda 60 microgram HA/strain suspensie voor injectie in voorgevulde spuit |
|---|
| 互认成员国 - 产品名称 | - Spain (ES)
- Bulgaria (BG)
Eflueida - Portugal (PT)
- Cyprus (CY)
Efluelda Suspension in injection in pre-filled syringe, 60 μg of Haemagglutinin/strain/0.5 ML - Italy (IT)
- Czechia (CZ)
Efluelda - Greece (GR)
- Romania (RO)
Efluelda suspensie injectabilă în seringă preumplută - Germany (DE)
- Sweden (SE)
- Slovakia (SK)
- Denmark (DK)
Efluelda - Norway (NO)
- Slovenia (SI)
- Belgium (BE)
- Finland (FI)
- Malta (MT)
- Luxembourg (LU)
- Poland (PL)
Efluelda - Croatia (HR)
- Iceland (IS)
- Latvia (LV)
- Ireland (IE)
- Lithuania (LT)
Efluelda, injekcinė suspensija užpildytame švirkšte Trivalentė vakcina nuo gripo (iš virionų fragmentų, inaktyvuota) 60 mikrogramų HA/padermė - Austria (AT)
- Estonia (EE)
- France (FR)
- Hungary (HU)
|
|---|
| 许可日期 | 2024/10/24 |
|---|
| 最近更新日期 | 2024/10/24 |
|---|
| 药物ATC编码 | |
|---|